Praxis Precision Medicines (PRAX) Cash from Operations (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Cash from Operations of 86152000.0 for Q1 2026, down 62.52% year-over-year from 229862971.61 in Q1 2025, and down 12.88% quarter-over-quarter from 76325000.0 in Q4 2025.
Praxis Precision Medicines (PRAX) Cash from Operations (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Cash from Operations history runs 8 years deep, the most recent figure standing at 86152000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 62.52% year-over-year to 86152000.0; the TTM figure through Mar 2026 stood at 282210000.0 (down 72.17% YoY), while the FY2025 annual figure was 249068000.0, down 89.04% from the prior year.
- Cash from Operations for Q1 2026 stood at 86152000.0, down from 76325000.0 in the prior quarter.
- The five-year high for Cash from Operations was 20857000.0 in Q1 2024, with the low at 86152000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 44919000.0 (2022), against an average of 44891529.41.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations soared 48.32% in 2023, then plunged 154.16% in 2025.
- Praxis Precision Medicines' Cash from Operations stood at 28806000.0 in 2022, then increased by 17.17% to 23861000.0 in 2023, then slumped by 135.2% to 56122000.0 in 2024, then plunged by 36.0% to 76325000.0 in 2025, then fell by 12.88% to 86152000.0 in 2026.
- Business Quant data shows PRAX's Cash from Operations at 86152000.0 in Q1 2026, 76325000.0 in Q4 2025, and 65057000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Praxis Precision Medicines | 10.24 Bn | 9.48 Bn | - | -77.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -77.54 Mn |
| Jun 30, 2026 | -77.54 Mn |
| Mar 31, 2026 | -86.15 Mn |
| Mar 31, 2026 | -86.15 Mn |
| Dec 31, 2025 | -76.33 Mn |
| Dec 31, 2025 | -76.33 Mn |
| Sep 30, 2025 | -65.06 Mn |
| Sep 30, 2025 | -65.06 Mn |
| Jun 30, 2025 | -54.68 Mn |
| Jun 30, 2025 | -54.68 Mn |
| Mar 31, 2025 | -53.01 Mn |
| Mar 31, 2025 | -53.01 Mn |
| Dec 31, 2024 | -56.12 Mn |
| Dec 31, 2024 | -56.12 Mn |
| Sep 30, 2024 | -27.50 Mn |
| Sep 30, 2024 | -27.50 Mn |
| Jun 30, 2024 | -27.28 Mn |
| Jun 30, 2024 | -27.28 Mn |
| Mar 31, 2024 | -20.86 Mn |
| Mar 31, 2024 | -20.86 Mn |